Andrew Bayliffe
Venture Partner @ Apple Tree Partners
London, United Kingdom
Andrew Bayliffe is a venture partner at ATP. With more than 20 years of leadership experience in the biopharmaceutical industry, he possesses expertise in the discovery and development of both small molecule and antibody therapeutics across a broad range of diseases areas. Most recently, at GlaxoSmithKline (GSK), he served as head of the Fibrosisand Lung Injury Discovery unit at GSK’s R&D headquarters in Stevenage, UK, and held senior roles in antibody discovery and development in the US and UK.Andrew is an honorary professor at the Wolfson Institute of Experimental Medicine at Queens College in Belfast. He completed his undergraduate and PhD studies in pharmacology, physiology, and molecular biology at Manchester University and Leeds University in the UK.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Andrew Bayliffe invests in
Stages Andrew Bayliffe invests in
Countries Andrew Bayliffe invests in
Investment Focus
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Marengo Therapeutics
|
Marengo Therapeutics is seeking professionals who are motivated to make a positive difference in patients’ lives. | $80M / Series A / Nov 08, 2021 | |
|
Marengo Therapeutics
|
Marengo Therapeutics is seeking professionals who are motivated to make a positive difference in patients’ lives. | $80M / Series B / Nov 08, 2021 |
About Apple Tree Partners
ATP, a global leader in life sciences venture capital, is developing the next generation of transformative biotechnology companies. ATP creates science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. The firm provides flexible capital, strategicinsight, and operational resources to build sustainable, research-driven enterprises. ATP invests in its portfolio companies from seed stage through IPO and beyond and supports their management teams in strategic transactions and synergistic business combinations.
Apple Tree Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexander McCampbell
Venture Partner
|
|||
|
Andrew Bayliffe
Venture Partner
|
|||
Anna Batarina
Partner
|
|||
Brian Vash
Entrepreneur in Residence
|
|||
Daniel Finkelman
General Counsel
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrew Bayliffe invest in?
Andrew Bayliffe invests primarily in Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrew Bayliffe last invest?
The most recent investment recorded for Andrew Bayliffe closed in Nov 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
